MolNFT v1 · #88784 · protein
Focal adhesion kinase catalytic domain
4D5H · Focal adhesion kinase 1: “Focal adhesion kinase catalytic domain”. X-ray diffraction, 2 ligands (9RM, SO4), 3 pockets (best druggability 0.77). MolNFT v1 #88784 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4D5H
- Type
- protein
- Length
- 515 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Focal adhesion kinase 1
- EC
- 2.7.10.2
- UniProt
- Q00944
- Ligands
- 9RM, SO4
- Pockets
- 3 · best druggability 0.77
Structure
x-ray diffraction · 2 distinct chains · 44% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Focal adhesion kinase 1 (EC 2.7.10.2) | protein | 255 | 44% helix, 18% strand | Q00944 |
| B | Focal adhesion kinase 1 (EC 2.7.10.2) | protein | 260 | 45% helix, 18% strand | Q00944 |
Ligands and binding sites
- 9RM · 6-methyl-5-{[3-(trifluoromethyl)phenyl]amino}-1,2,4-triazin-3(4H)-one · ligand · chains A
- SO4 · Sulfate ion · ion · 4 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 888 | 0.77 | 0.80 | 90 | 9RM, SO4 |
| 2 | 360 | 0.64 | 0.79 | 53 | empty |
| 3 | 59 | 0.35 | 0.78 | 12 | empty |
Interfaces
1 interface between chains.
- A–B · 610 Ų buried · 11 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q00944
- Elsewhere: RCSB PDB 4D5H · PDBe 4D5H · UniProt Q00944
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.